Literature DB >> 25053415

c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate.

Lia R Edmunds1, Lokendra Sharma1, Audry Kang1, Jie Lu1, Jerry Vockley2, Shrabani Basu2, Radha Uppala2, Eric S Goetzman2, Megan E Beck2, Donald Scott3, Edward V Prochownik4.   

Abstract

myc(-/-) rat fibroblasts (KO cells) differ from myc(+/+) (WT) cells and KO cells with enforced Myc re-expression (KO-Myc cells) with respect to mitochondrial structure and function, utilization of glucose and glutamine as energy-generating substrates, and ATP levels. Specifically, KO cells demonstrate low levels of glycolysis and oxidative phosphorylation, dysfunctional mitochondria and electron transport chain complexes, and depleted ATP stores. We examined here how these cells adapt to their energy-deficient state and how they differ in their uptake and utilization of long- and medium-chain fatty acids such as palmitate and octanoate, respectively. Metabolic tracing of these molecules showed that KO cells preferentially utilize them as β-oxidation substrates and that, rather than directing them into phospholipids, preferentially store them as neutral lipids. KO cell transcriptional profiling and functional assays revealed a generalized up-regulation of pathways involved in fatty acid transport and catabolism as well as evidence that these cells attempt to direct acetyl-CoA into the tricarboxylic acid (TCA) cycle for ATP production rather than utilizing it for anabolic purposes. Additional evidence to support this idea included the finding that AMP-dependent protein kinase was constitutively activated in KO cells. The complex control of pyruvate dehydrogenase, which links glycolysis to the TCA cycle, was also maximized to ensure the conversion of pyruvate to acetyl-CoA. Despite these efforts to maximize acetyl-CoA for energy-generating purposes, its levels remained chronically low in KO cells. This suggests that tumor cells with Myc deregulation might be susceptible to novel therapies that limit acetyl-CoA availability.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  AMP-activated Kinase (AMPK); Electron Transfer Complex; Mitochondria; Pyruvate Dehydrogenase Complex (PDC); Tricarboxylic Acid Cycle (TCA Cycle) (Krebs cycle); Warburg Effect

Mesh:

Substances:

Year:  2014        PMID: 25053415      PMCID: PMC4155699          DOI: 10.1074/jbc.M114.580662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.

Authors:  Mayumi Tamada; Makoto Suematsu; Hideyuki Saya
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

2.  AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo.

Authors:  Brandon Faubert; Gino Boily; Said Izreig; Takla Griss; Bozena Samborska; Zhifeng Dong; Fanny Dupuy; Christopher Chambers; Benjamin J Fuerth; Benoit Viollet; Orval A Mamer; Daina Avizonis; Ralph J DeBerardinis; Peter M Siegel; Russell G Jones
Journal:  Cell Metab       Date:  2012-12-27       Impact factor: 27.287

Review 3.  Metabolic pathway alterations that support cell proliferation.

Authors:  M G Vander Heiden; S Y Lunt; T L Dayton; B P Fiske; W J Israelsen; K R Mattaini; N I Vokes; G Stephanopoulos; L C Cantley; C M Metallo; J W Locasale
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-01-19

Review 4.  Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.

Authors:  Barbara Chaneton; Eyal Gottlieb
Journal:  Trends Biochem Sci       Date:  2012-05-23       Impact factor: 13.807

Review 5.  AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

6.  A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.

Authors:  Joanna Kaplon; Liang Zheng; Katrin Meissl; Barbara Chaneton; Vitaly A Selivanov; Gillian Mackay; Sjoerd H van der Burg; Elizabeth M E Verdegaal; Marta Cascante; Tomer Shlomi; Eyal Gottlieb; Daniel S Peeper
Journal:  Nature       Date:  2013-05-19       Impact factor: 49.962

7.  Mn porphyrin regulation of aerobic glycolysis: implications on the activation of diabetogenic immune cells.

Authors:  Meghan M Delmastro-Greenwood; Tatyana Votyakova; Eric Goetzman; Meghan L Marre; Dana M Previte; Artak Tovmasyan; Ines Batinic-Haberle; Massimo M Trucco; Jon D Piganelli
Journal:  Antioxid Redox Signal       Date:  2013-07-05       Impact factor: 8.401

8.  MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells.

Authors:  Hanna Zirath; Anna Frenzel; Ganna Oliynyk; Lova Segerström; Ulrica K Westermark; Karin Larsson; Matilda Munksgaard Persson; Kjell Hultenby; Janne Lehtiö; Christer Einvik; Sven Påhlman; Per Kogner; Per-Johan Jakobsson; Marie Arsenian Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

9.  Mitochondrial structure, function and dynamics are temporally controlled by c-Myc.

Authors:  J Anthony Graves; Yudong Wang; Sunder Sims-Lucas; Edward Cherok; Kristi Rothermund; Maria F Branca; Jennifer Elster; Donna Beer-Stolz; Bennett Van Houten; Jerry Vockley; Edward V Prochownik
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

10.  Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients.

Authors:  Celine Aguer; Marc Foretz; Louise Lantier; Sophie Hebrard; Benoit Viollet; Jacques Mercier; Magali Kitzmann
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

View more
  44 in total

Review 1.  MYC and metabolism on the path to cancer.

Authors:  Annie L Hsieh; Zandra E Walton; Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

Review 2.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

3.  Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.

Authors:  Huabo Wang; Jie Lu; Lia R Edmunds; Sucheta Kulkarni; James Dolezal; Junyan Tao; Sarangarajan Ranganathan; Laura Jackson; Marc Fromherz; Donna Beer-Stolz; Radha Uppala; Sivakama Bharathi; Satdarshan P Monga; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

4.  RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells.

Authors:  Su-Hyeong Kim; Eun-Ryeong Hahm; Krishna B Singh; Sruti Shiva; Jacob Stewart-Ornstein; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 5.  Oncogene-directed alterations in cancer cell metabolism.

Authors:  Arvindhan Nagarajan; Parmanand Malvi; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2016-06-27

Review 6.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

Review 7.  Redox-sensitive signaling in inflammatory T cells and in autoimmune disease.

Authors:  Cornelia M Weyand; Yi Shen; Jorg J Goronzy
Journal:  Free Radic Biol Med       Date:  2018-03-07       Impact factor: 7.376

8.  Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS.

Authors:  Blake M Bluestein; Fionnuala Morrish; Daniel J Graham; Li Huang; David Hockenbery; Lara J Gamble
Journal:  Biointerphases       Date:  2018-08-28       Impact factor: 2.456

Review 9.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 10.  Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.

Authors:  Abudureyimu Tuerhong; Jin Xu; Si Shi; Zhen Tan; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Wei Wang; Xianjun Yu; Chen Liang
Journal:  Cell Mol Life Sci       Date:  2021-06-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.